Integrated ProteinsBOM:519606 -2.84%45 EBITDA Margin % is 4.07% as of Mar. 2026, which is 82% below its 10-year median of 22.60. GuruFocus rates BOM:519606 with a GF Score™ of 45/100 and a GF Value™ of ₹141.24 (Fairly Valued). The stock has 4 warning signs investors should review. Among 1,949 Consumer Packaged Goods companies, Integrated Proteins ranks worse than 74.65% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Integrated Proteins EBITDA Margin % Related Terms
Integrated Proteins EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Integrated Proteins's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:519606 vs ADM, BG, TSN: EBITDA Margin % Comparison
For the Farm Products subindustry, Integrated Proteins's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integrated Proteins EBITDA Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Integrated Proteins's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Integrated Proteins's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Integrated Proteins (BOM:519606) has a EBITDA Margin % of 4.07% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Integrated Proteins and its competitors. This is 82% below median its historical median of 22.60. Over the past decade, Integrated Proteins' EBITDA Margin % has ranged from 1.53 to 54.93. According to the industry distribution chart, Integrated Proteins ranks #1455 out of 1949 companies in the Consumer Packaged Goods industry, placing it in the top 74.7%.
Is Integrated Proteins' EBITDA Margin % too high?
Integrated Proteins' current EBITDA Margin % of 4.07% is 82% below median its 10-year median of 22.60. Over the past 10 years, this metric has ranged from a low of 1.53 to a high of 54.93. The Consumer Packaged Goods industry median EBITDA Margin % is 8.97. Integrated Proteins' value of 4.07% is 54.6% below this industry median. Based on the distribution chart, Integrated Proteins ranks #1455 out of 1949 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Integrated Proteins has a GF Score™ of 45/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Integrated Proteins' EBITDA Margin % compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Integrated Proteins ranks #1455 out of 1949 companies for EBITDA Margin %. This places Integrated Proteins in the lower half of its industry. The industry median EBITDA Margin % is 8.97. Integrated Proteins' value of 4.07% is 54.6% below this benchmark. Historically, Integrated Proteins' own EBITDA Margin % has ranged from 1.53 to 54.93 over the past decade. While the company's 10-year median is 22.60 vs. the industry median of 8.97, Integrated Proteins has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 8.97, based on 1,949 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Integrated Proteins's current EBITDA Margin % of 4.07% is 54.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Integrated Proteins and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 8.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Integrated Proteins's current EBITDA Margin % is 4.07%, which is 82% below median its own 10-year median of 22.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integrated Proteins stock overvalued right now?
Based on GuruFocus' analysis, Integrated Proteins (BOM:519606) is currently considered Fairly Valued. The stock's GF Value™ is ₹141.24, compared to a current price of ₹142.10 — trading 0.6% above its estimated fair value. The current EBITDA Margin % is 4.07%, which is 82% below median its 10-year median of 22.60 and 54.6% below the Consumer Packaged Goods industry median of 8.97. Integrated Proteins' overall GF Score™ is 45/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Integrated Proteins (BOM:519606), the current EBITDA Margin % is 4.07% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Integrated Proteins (BOM:519606) Overvalued in 2026?
Based on GuruFocus' analysis, Integrated Proteins stock appears to be overvalued.
The current stock price of ₹142.10 is trading 0.6% above its estimated GF Value™ of ₹141.24.
GuruFocus considers Integrated Proteins to be Fairly Valued.
Key valuation signals for BOM:519606:
EBITDA Margin %: 4.07% (82% below median its 10-year median of 22.60)
GF Value™: ₹141.24 vs. price of ₹142.10 (0.6% above fair value)
Industry Position: 54.6% below the Consumer Packaged Goods median (#1455 of 1949)
No single metric tells the full story. See the BOM:519606 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Integrated Proteins Ltd is engaged in the business of Trading in the processing of various oil seeds like soyabean, mustard/rapeseed, groundnut, as well as trading in Agri commodities, products, etc.
45GF Score
Get the complete analysis for BOM:519606
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:519606 has been successfully added to your 
